Author:
Johnson Daniel E.,O'Keefe Rachel A.,Grandis Jennifer R.
Publisher
Springer Science and Business Media LLC
Reference255 articles.
1. Kumari, N., Dwarakanath, B. S., Das, A. & Bhatt, A. N. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 37, 11553–11572 (2016).
2. Kusaba, T. et al. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol. Rep. 15, 1445–1451 (2006).
3. Chen, Y., et al. STAT3, a poor survival predicator, is associated with lymph node metastasis from breast cancer. J. Breast Cancer 16, 40–49 (2013).
4. Macha, M. A. et al. Prognostic significance of nuclear pSTAT3 in oral cancer. Head Neck 33, 482–489 (2011).
5. Ludwig, H., Nachbaur, D. M., Fritz, E., Krainer, M. & Huber, H. Interleukin-6 is a prognostic factor in multiple myeloma. Blood 77, 2794–2795 (1991).
Cited by
1725 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献